The glycemic profile of GDM women improved with MED post-delivery with significant reductions in fasting insulin [MED = 2.5 mcUI/ml (2.0–5.6) vs. control = 4.6 mcUI/ml (2.0–7.7), p < 0.05], in contrast, fasting blood glucose levels did not improve. This evidence concerns the gene INS and gestational diabetes.